# Effect of Hyperuricaemia on Chronic Renal Disease

> **NCT03425708** · PHASE4 · UNKNOWN · sponsor: **The Affiliated Hospital of Xuzhou Medical University** · enrollment: 400 (estimated)

## Conditions studied

- Hyperuricemia
- Chronic Renal Disease

## Interventions

- **DRUG:** 20mg Febuxostat
- **DRUG:** 40mg Febuxostat

## Key facts

- **NCT ID:** NCT03425708
- **Lead sponsor:** The Affiliated Hospital of Xuzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-01
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2018-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03425708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03425708, "Effect of Hyperuricaemia on Chronic Renal Disease". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03425708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*